3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Carcinoma, Renal Cell
38
Kidney Neoplasms
20
Melanoma
14
Neoplasm Metastasis
13
Prostatic Neoplasms
6
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Uterine Cervical Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Transitional Cell
4
Carcinoma, Merkel Cell
4
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
3
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Lymphoma
2
Carcinoma, Hepatocellular
2
Anus Neoplasms
2
Vaginal Neoplasms
1
Turcot syndrome
1
Skin Neoplasms
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Multiple Myeloma
1
Microsatellite Instability
1
Mesothelioma, Malignant
1
Interventions
pembrolizumab
6
Sorafenib
4
Filgrastim
4
Carboplatin
4
Thiotepa
3
Radiotherapy
3
Psychiatric Rehabilitation
3
Nivolumab
3
Ipilimumab
3
Cyclophosphamide
3
sargramostim
2
ixabepilone
2
fludarabine
2
Temozolomide
2
Sirolimus
2
Polymerase Chain Reaction
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Ifosfamide
2
Granulocyte Colony-Stimulating Factor
2
Gene Expression Profiling
2
Etoposide
2
Drug Therapy
2
Counseling
2
Busulfan
2
Bupropion
2
Blood Specimen Collection
2
Biopsy
2
vofatamab
1
utomilumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Interleukin-2
×
Genitourinary
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled